Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Molecules ; 29(12)2024 Jun 18.
Article in English | MEDLINE | ID: mdl-38930950

ABSTRACT

Antibodies are widely used in medicinal and scientific research due to their ability to bind to a specific antigen. Most often, antibodies are composed of heavy and light chain domains. Under physiological conditions, light chains are produced in excess, as compared to the heavy chain. It is now known that light chains are not silent partners of the heavy chain and can modulate the immune response independently. In this work, the first crystal structure of a light chain dimer originating from mice is described. It represents the light chain dimer of 6A8, a monoclonal antibody specific to the allergen Der f 1. Building on the unexpected occurrence of this kind of dimer, we have demonstrated that this light chain is stable in solution alone. Moreover, enzyme-linked immunosorbent assays (ELISA) have revealed that, when the light chain is not partnered to its corresponding heavy chain, it interacts non-specifically with a wide range of proteins. Computational studies were used to provide insight on the role of the 6A8 heavy chain domain in the specific binding to Der f 1. Overall, this work demonstrates and supports the ongoing notion that light chains can function by themselves and are not silent partners of heavy chains.


Subject(s)
Immunoglobulin Light Chains , Protein Multimerization , Animals , Mice , Immunoglobulin Light Chains/chemistry , Immunoglobulin Light Chains/metabolism , Antibodies, Monoclonal/chemistry , Antibodies, Monoclonal/immunology , Models, Molecular , Protein Binding , Crystallography, X-Ray , Protein Conformation , Immunoglobulin Heavy Chains/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...